Medication info

Pralcoholcalciferol Injection

Prescription medicationInjectionsIntramuscular injection
Ingredient · strength
Cholecalciferol›5mg / 1mL
Manufacturer / importer
Pharma Research Co., Ltd.
Appearance
A transparent pale yellow liquid in a brown glass ampoule.
Packaging
0.5 milliliters/box [0.5 milliliters/ampoule × 5], 1 milliliter/box [1 milliliter/ampoule × 5]
Approval status
Active

MFDS item code 202106881 · Notified 2021.10.13

Summary

Main use
Prevention and treatment of vitamin D deficiency
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, adjusting the dose based on the blood 25-hydroxyvitamin D level. In adults, the therapeutic effect and tolerability should be reviewed within 3 months after administration of this medicine, and the decision on whether to administer it again should be based on this review. Because overdose may increase adverse reactions, do not administer more than the required amount. Adults: Administer 200,000IU of cholecalciferol by intramuscular injection. Older adults: Administer 100,000IU of cholecalciferol by intramuscular injection. Do not exceed an annual dose of 600,000IU of cholecalciferol.
Child administration
Adolescents: Administer 200,000IU of cholecalciferol by intramuscular injection. The therapeutic effect and tolerability should be reviewed within 6 months after administration of this medicine, and the decision on whether to administer it again should be based on this review.

Ingredients

Manufacturer
Pharma Research Co., Ltd.

Efficacy & effects

Prevention and treatment of vitamin D deficiency

View approved original text

Used for the prevention and treatment of vitamin D deficiency in elderly patients, adolescents, and adults. This medication improves health issues due to vitamin D deficiency, helps maintain bone health, and supports normal bodily functions. Thus, it is effective in preventing and treating conditions such as osteoporosis or osteomalacia that may arise from vitamin D deficiency.

How it is given

Adult administration

Use as prescribed by a physician, adjusting the dose based on the blood 25-hydroxyvitamin D level. In adults, the therapeutic effect and tolerability should be reviewed within 3 months after administration of this medicine, and the decision on whether to administer it again should be based on this review. Because overdose may increase adverse reactions, do not administer more than the required amount. Adults: Administer 200,000IU of cholecalciferol by intramuscular injection. Older adults: Administer 100,000IU of cholecalciferol by intramuscular injection. Do not exceed an annual dose of 600,000IU of cholecalciferol.

Child administration

Adolescents: Administer 200,000IU of cholecalciferol by intramuscular injection. The therapeutic effect and tolerability should be reviewed within 6 months after administration of this medicine, and the decision on whether to administer it again should be based on this review.

Precautions

This medication contains vitamin D, so to avoid overdose, check the total vitamin D content when taking other medications or fortified foods that contain vitamin D. Regularly check calcium levels in the blood, and if they exceed the normal range, discontinue the medication. Additionally, monitor calcium excretion in the urine. When calcium intake is high, regularly check blood and urinary calcium levels to avoid any abnormalities. This medication should not be used by patients who have allergies to its ingredients, hypercalcemia, hypercalciuria, calcium stones, poor kidney function, limited mobility, specific diseases, or by women who are pregnant or breastfeeding. Side effects such as headaches, fatigue, muscle pain, indigestion, dehydration, elevated blood pressure, kidney issues, and skin rashes may occur while taking this medication, so consult medical personnel immediately if symptoms arise. In patients with low vitamin D levels, regular monitoring of serum vitamin D levels is necessary to prevent overdose. Creatinine levels should be tested every 3 to 6 months to assess kidney function, especially in older adults or patients taking specific medications. As this medication may interact with other drugs, patients taking anticonvulsants, steroids, certain diuretics, antacids, or warfarin should consult a doctor or pharmacist. It should not be used during pregnancy, as overdose can cause physical and mental issues in children, so caution is necessary. Safety and efficacy in children under 12 years of age have not been established, so it is not recommended. In cases of overdose, discontinue medication immediately, reduce calcium intake, ensure adequate hydration, and treatment to promote diuresis may be needed. Do not mix this medication with others, use it quickly after opening, and dispose of any remaining medication. Store in a container that does not allow light to enter and at room temperature between 1 and 30 degrees Celsius to maintain effectiveness.

Side effects

headache, weakness, fatigue, myalgia, loss of appetite, weight loss, growth retardation, nausea, vomiting, constipation, diarrhea, polyuria, polydipsia, dehydration, hypertension, calcium stones, calcification of kidney and vascular tissues, kidney impairment, excessive bone calcification, arrhythmia, psychological symptoms, awareness disturbance, arthralgia, myasthenia, drowsiness, azotemia, hypersensitivity reactions, thirst, confusion, bloating, abdominal pain, metallic taste, dry mouth, rash, itching, hypercalciuria, hypercalcemia, hyperphosphatemia, hyperphosphaturia, injection site granuloma, injection site nodule, injection site reaction, injection site urticaria, injection site infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that does not allow light to pass through. It is also advisable to store it at room temperature between 1 and 30 degrees Celsius. This storage method helps maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

A transparent pale yellow liquid in a brown glass ampoule.

Package unit

0.5 milliliters/box [0.5 milliliters/ampoule × 5], 1 milliliter/box [1 milliliter/ampoule × 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.